ES530439A0 - Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina. - Google Patents

Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.

Info

Publication number
ES530439A0
ES530439A0 ES530439A ES530439A ES530439A0 ES 530439 A0 ES530439 A0 ES 530439A0 ES 530439 A ES530439 A ES 530439A ES 530439 A ES530439 A ES 530439A ES 530439 A0 ES530439 A0 ES 530439A0
Authority
ES
Spain
Prior art keywords
urine
constituents
type
body fluids
various diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530439A
Other languages
English (en)
Other versions
ES8605098A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3897583A external-priority patent/JPS59164960A/ja
Priority claimed from JP5149583A external-priority patent/JPS59178361A/ja
Priority claimed from JP5149483A external-priority patent/JPS59178360A/ja
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Publication of ES530439A0 publication Critical patent/ES530439A0/es
Publication of ES8605098A1 publication Critical patent/ES8605098A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/969—Multiple layering of reactants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES530439A 1983-03-11 1984-03-09 Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina. Expired ES8605098A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3897583A JPS59164960A (ja) 1983-03-11 1983-03-11 抗原決定基具有物質の測定法
JP5149583A JPS59178361A (ja) 1983-03-29 1983-03-29 抗原決定基具有物質測定法
JP5149483A JPS59178360A (ja) 1983-03-29 1983-03-29 抗原決定基具有物質測定方法

Publications (2)

Publication Number Publication Date
ES530439A0 true ES530439A0 (es) 1986-03-01
ES8605098A1 ES8605098A1 (es) 1986-03-01

Family

ID=27289998

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530439A Expired ES8605098A1 (es) 1983-03-11 1984-03-09 Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.

Country Status (4)

Country Link
US (1) US4621048A (es)
EP (1) EP0119767B1 (es)
DE (1) DE3483620D1 (es)
ES (1) ES8605098A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485339D1 (de) * 1983-11-18 1992-01-23 Fujirebio Kk Verfahren zur messung eines biologischen ligands.
US4757001A (en) * 1984-02-16 1988-07-12 Fujirebio Kabushiki Kaisha Method of measuring biological ligand by utilizing amylase
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
AU7238087A (en) * 1986-03-26 1987-10-20 Murex Corp. Anti-enzyme antibody immunoassay
EP0310940B1 (en) * 1987-09-30 1994-11-23 Fujirebio Kabushiki Kaisha Analytical element for enzyme immunoassays
DE3807440A1 (de) * 1988-03-07 1989-09-21 Progen Biotechnik Gmbh Verfahren zum immunologischen nachweis von substanzen sowie eine derartige zusammensetzung und ein testkit
US5178988A (en) * 1988-09-13 1993-01-12 Amp-Akzo Corporation Photoimageable permanent resist
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
DK0487301T3 (da) * 1990-11-20 2000-09-18 Dade Behring Marburg Gmbh Fremgangsmåde til stabilisering af enzymkonjugater
US5565326A (en) * 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5650324A (en) * 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5916757A (en) * 1994-05-31 1999-06-29 Johnson & Johnson Clinical Diagnostics, Inc. Specific binding assay using enzyme inhibitor and anti-inhibitor antibodies
US5567581A (en) * 1995-03-06 1996-10-22 Diagnostic Reagents, Inc. Method and kit for enzymatically determining the pH of a specimen
US20040157262A1 (en) * 1996-04-30 2004-08-12 Michel Kohl Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
KR20010025027A (ko) * 1998-05-15 2001-03-26 타다시 마츠다 면역측정시약 및 면역측정법
US6306273B1 (en) * 1999-04-13 2001-10-23 Aclara Biosciences, Inc. Methods and compositions for conducting processes in microfluidic devices
SE0400886D0 (sv) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4160645A (en) * 1977-07-14 1979-07-10 Syva Company Catalyst mediated competitive protein binding assay
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
IL67289A (en) * 1982-03-18 1985-12-31 Miles Lab Homogeneous immunoassay with labeled monoclonal anti-analyte
US4446233A (en) * 1982-05-05 1984-05-01 E. I. Du Pont De Nemours And Company Homogeneous immunoassay using covalent hybrid antibodies
FR2542871B1 (fr) * 1983-03-15 1986-05-16 Pasteur Institut Procede de dosage en phase heterogene de substances biologiques antigeniques, mettant en oeuvre des conjugues hybrides d'anticorps et reactifs pour sa mise en oeuvre

Also Published As

Publication number Publication date
EP0119767A2 (en) 1984-09-26
EP0119767A3 (en) 1988-01-27
ES8605098A1 (es) 1986-03-01
EP0119767B1 (en) 1990-11-22
US4621048A (en) 1986-11-04
DE3483620D1 (de) 1991-01-03

Similar Documents

Publication Publication Date Title
ES530439A0 (es) Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.
DK161340C (da) Diagnostisk middel til paavisning af leukocytter i legemsvaesker, fremgangsmaade til dets fremstilling samt dets anvendelse
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
IL73570A0 (en) Desulfatohirudins,their preparation and pharmaceutical compositions containing them
NL7603038A (nl) Wegwerpbaar stromingssysteem voor het behandelen van bloed en andere biologische cellen.
JPS54109291A (en) Heater structure for instillation liquid* transfusion blood or like
DK42982A (da) Apparat til registrering af glukosekoncentration i biologiske fluida
NL190397C (nl) Dialysesonde voor toepassing in een biologisch weefsel, zoals hersenweefsel.
BE866698A (fr) Poche pour recueillir, conserver et administrer notamment filtrer du sang, des constituants sanguins et des fluides intraveineux et similaires
HU172449B (hu) Diagnosticheskaja lenta dlja ispytanija dlja vyjavlenija krovi i drugikh vehhestv s peroksidativnym ehffektom v biologicheskikh zhidkostjakh tela
ZA796880B (en) Agent for the detetction of leukocytes in body fluids
GB2152215B (en) Method for the quantitative determination of physiological components in biological fluids
ES521401A0 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
IT1116032B (it) Composizione e procedimento per la determinazione della concentrazione del glucosio in fluidi corporei
IT1203671B (it) Reagente per la determinazione del la funzione di coagulazione del sangue e procedimento per la sua preparazione
GB2100864B (en) Investigating substances in bloodstream and detecting blood flow
NL187299C (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
IT1065244B (it) Mezzo diagnostico per l'identificazione di sangue ed altre sostanze ad attivita'ferrostdasica in liquidi fisiologici
ZA805898B (en) Assay for the free portion of substances in biological fluids
EP0292019A3 (en) Process for measuring the content of component in vital fluid such as urine and blood
GB2005017B (en) Rapid diagnostic for the determination of uric acid in body fluids
DK158985D0 (da) Konjugat af et protein med et cytotoksisk middel, fremgangsmaade til dets fremstilling og anvendelse heraf i reagenssaet til tumorbehandlingeller -analyse
AT330366B (de) Verfahren zur bestimmung des gesamtbilirubingehaltes in korperflussigkeiten

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401